role
angiotensin
ii
ang
ii
dengu
viru
infect
remain
unknown
aim
studi
determin
effect
losartan
antagonist
angiotensin
ii
type
receptor
receptor
enalapril
inhibitor
angiotensin
iconvert
enzym
ace
viral
antigen
express
product
periton
macrophag
infect
dengu
viru
type
mice
treat
losartan
enalapril
untreat
control
infect
intraperiton
viru
macrophag
analyz
infect
result
increas
product
high
percentag
cell
express
viral
antigen
decreas
treatment
antiang
ii
drug
suggest
role
ang
ii
dengu
viru
infect
dengu
frequent
human
vectorborn
viral
diseas
dengu
viru
denv
mosquitoborn
viru
belong
famili
flavivirida
envelop
singlestrand
positivesens
rna
viru
four
genet
distinct
denv
serotyp
caus
diseas
human
denv
infect
level
sever
cytokin
cytokin
receptor
apoptosi
found
increas
human
experiment
infect
increas
express
infect
denv
cell
probabl
play
import
role
pathogenesi
dengu
reninangiotensin
system
involv
regul
blood
pressur
vasoconstrict
sodium
intak
potassium
excret
angiotensin
ii
ang
ii
one
main
effector
molecul
system
proinflammatori
properti
report
recent
bind
ang
ii
receptor
particular
angiotensin
ii
type
receptor
receptor
intracellular
transloc
nfkb
nucleu
occur
induc
transcript
proinflammatori
cytokin
product
oxygenreact
speci
ang
iimedi
inflammatori
event
inhibit
use
receptor
antagonist
inhibit
angiotensin
convert
enzym
ace
ang
ii
involv
product
sever
cytokin
includ
also
involv
virusinduc
respiratori
pathogenesi
inform
suggest
ang
ii
import
factor
inflammatori
event
viru
infect
avail
inform
regard
role
ang
ii
denv
infect
therefor
aim
studi
determin
effect
losartan
angiotensin
ii
receptor
antagonist
enalapril
inhibitor
ace
cellular
express
viral
antigen
product
periton
macrophag
infect
adult
male
nmri
mice
weigh
g
central
anim
facil
instituto
de
investigacion
ivic
venezuela
use
anim
hous
room
temperatur
water
food
ratarina
protein
valencia
venezuela
ad
libitum
natur
daynight
light
cycl
viru
strain
new
guinea
c
propag
mosquito
cell
cultur
eagl
mem
medium
contain
fb
prior
infect
mice
viruscontain
cultur
medium
harvest
day
incub
remov
cell
debri
centrifug
supernat
aliquot
store
use
viru
titrat
plaqu
format
assay
vero
cell
cell
seed
cellswel
plate
subsequ
serial
dilut
viru
ad
mixtur
incub
day
afterward
plaqu
visual
stain
dye
solut
contain
crystal
violet
viru
concentr
given
plaqueform
unit
pfu
ml
mice
left
untreat
treat
losartan
enalapril
merck
co
whitehous
station
nj
usa
gavag
mgkgday
entir
experiment
period
one
week
treatment
untreat
treat
mice
inject
intraperiton
ip
ml
thioglycol
solut
difco
laboratori
detroit
mi
usa
elicit
inflammatori
macrophag
four
day
later
mice
infect
ip
suspens
moi
base
assumpt
condit
approxim
periton
cell
ml
usual
obtain
six
group
anim
studi
per
group
losartantr
enalapriltr
untreat
infect
anim
losartantr
enalapriltr
untreat
uninfect
anim
hour
intraperiton
incub
ml
cold
steril
pb
inject
ip
macrophag
periton
fluid
obtain
centrifug
rpm
min
anim
portion
macrophag
sampl
homogen
supernat
periton
fluid
homogen
kept
need
determin
anoth
portion
macrophag
prepar
cellsml
cytocentrifug
measur
cellular
express
identifi
cell
macrophag
fix
minut
cold
aceton
paraformaldehyd
determin
viral
antigen
macrophag
antigen
respect
intracellular
viral
antigen
detect
cytocentrifug
macrophag
direct
immunofluoresc
assay
use
fluoresceinconjug
monoclon
antibodi
chemicon
intern
inc
usa
macrophag
also
identifi
separ
sampl
use
fluoresceinconjug
monoclon
antimurin
antibodi
ebiosci
inc
san
diego
ca
usa
two
hundr
cell
count
percentag
posit
cell
monoclon
antibodi
determin
content
determin
elisa
biotra
amersham
int
england
express
pgmg
cellular
protein
pgml
periton
fluid
total
protein
content
macrophag
homogen
measur
use
bicinchonin
acid
assay
data
express
mean
standard
deviat
analyz
anova
follow
bonferroni
test
pvalu
less
consid
statist
signific
periton
macrophag
obtain
periton
caviti
hour
viral
interact
determin
presenc
viral
antigen
cell
time
high
percentag
periton
macrophag
untreat
infect
mice
posit
reveal
immunofluoresc
assay
antidenv
monoclon
antibodi
indic
penetr
cell
occur
infect
cell
treat
losartan
enalapril
show
reduc
express
viral
antigen
fig
addit
periton
fluid
macrophag
content
homogen
test
presenc
cytokin
relat
viral
infect
viral
express
accompani
increas
b
level
periton
fluid
periton
macrophag
suggest
macrophag
involv
increas
product
cytokin
losartan
treatment
result
decreas
product
denguevirusinfect
cell
enalapril
affect
product
fig
resid
macrophag
lower
level
pgmg
protein
pgml
cellular
periton
fluid
content
respect
observ
macrophag
elicit
thioglycol
treatment
high
percentag
cell
observ
suggest
macrophag
main
cell
type
analyz
studi
dengu
infect
interact
monocytesmacrophag
denv
occur
inflammatori
environ
gener
normal
periton
caviti
matur
resid
macrophag
inflam
periton
caviti
immatur
inflammatori
macrophag
recruit
circul
margin
pool
therefor
inflammatori
macrophag
obtain
periton
thioglycol
stimul
challeng
b
fig
effect
losartan
enalapril
dengu
viru
express
periton
macrophag
losartan
enalapril
treatment
result
decreas
percentag
macrophag
express
type
dengu
viru
antigen
detect
use
fluoresceinconjug
monoclon
antibodi
origin
magnif
order
examin
express
viral
antigen
product
effect
antiang
ii
drug
paramet
studi
last
year
document
new
role
ang
ii
proinflammatori
molecul
bind
ang
ii
receptor
particular
mediat
intracellular
transloc
nfkb
nucleu
product
oxygenreact
speci
proinflammatori
molecul
contribut
tissu
damag
block
ang
ii
signal
antagonist
inhibit
ace
protect
effect
togeth
find
suggest
possibl
target
ang
ii
signal
therapeut
intervent
inflammatori
diseas
sinc
dengu
inflammatori
diseas
justifi
studi
effect
antiang
ii
drug
diseas
addit
antiang
ii
drug
sever
experiment
model
inflammatori
diseas
report
effect
ang
ii
viral
infect
extens
studi
role
ang
ii
viral
respiratori
pathogenesi
document
recent
regard
influenza
viru
infect
accompani
increas
ang
ii
level
inflammatori
event
high
viral
titer
lung
tissu
associ
diseas
progress
mortal
reduc
treatment
losartan
proteolyt
process
promot
sar
coronaviru
entri
host
cell
induc
lung
pathogenesi
addit
enhanc
ace
activ
high
level
ang
ii
parallel
reduc
viral
acut
respiratori
distress
syndrom
also
document
vitro
studi
shown
decreas
superoxid
overproduct
rhinovirusinfect
cell
treat
losartan
inform
indic
possibl
role
ang
ii
viral
pathogenesi
accordingli
block
receptor
losartan
inhibit
ace
enalapril
reduc
percentag
macrophag
express
antigen
suggest
decreas
cell
penetr
viru
role
ang
ii
dengu
infect
mechan
ang
ii
affect
dengu
viru
penetr
regul
remain
unclear
howev
interact
viru
receptor
phagocytosi
receptor
could
involv
high
level
cytokin
product
patient
sever
dengu
denguevirusinfect
monocytemacrophag
cultur
report
proinflammatori
cytokin
play
import
role
dengu
studi
increas
level
found
macrophag
periton
fluid
periton
infect
treatment
losartan
enalapril
decreas
level
compart
suggest
role
receptor
product
possibl
role
ang
ii
dengu
infect
ang
ii
capabl
induc
product
interact
receptor
via
transloc
nfjb
nucleu
howev
rule
effect
denv
macrophag
biolog
regard
periton
macrophag
function
could
affect
denvinduc
cytotox
factor
produc
immunosuppress
affect
product
decreas
product
observ
receptor
block
decreas
observ
infect
untreat
enalapriltr
anim
suggest
role
receptor
activ
instead
cytotox
effect
induc
infect
report
relationship
ang
ii
dengu
fever
human
experiment
studi
current
experiment
protocol
repres
model
dengu
diseas
human
howev
allow
interact
denv
macrophag
studi
vivo
inflammatori
environ
studi
show
ang
ii
could
import
pathogenesi
dengu
infect
induc
increas
viral
infect
cytokin
product
investig
regard
role
ang
ii
pathogenesi
dengu
human
need
